Differences in Nutritional and Functional Assessment Scores Between Elderly Participants Receiving Home Delivered Meals (HDM) Versus those on a Waiting List (WL) to Receive the Meals

1998 ◽  
Vol 98 (9) ◽  
pp. A71
Author(s):  
A.T. Sweeney ◽  
C.O. Mitchell ◽  
P. Stephens ◽  
D.K. Polly
Keyword(s):  
Functional Assessment ◽  
Waiting List ◽  
Assessment Scores ◽  
To Receive

The pressure wire as a diagnostic tool in patients with congenital cardiac disease

2011 ◽  
Vol 21 (3) ◽  
pp. 317-320 ◽  
Author(s):  
Tahir Hamid ◽  
Haider Hadi ◽  
Bernard Clarke ◽  
Vaikom Mahadevan
Keyword(s):  
Pulmonary Artery ◽  
Functional Assessment ◽  
Cardiac Disease ◽  
Clinical Severity ◽  
Coronary Artery Lesions ◽  
Pressure Wire ◽  
Congenital Cardiac Disease ◽  
Appropriate Therapy ◽  
To Receive ◽  
Adequate Data

AbstractThe pressure wire has emerged as a useful tool to assess the clinical severity of moderate coronary artery lesions. We report a novel use of the pressure wire in adult patients with complex congenital cardiac disease in whom it was used in assessing pressures beyond the stenosis in the distal pulmonary artery, aorto-pulmonary collaterals, and across prosthetic tricuspid valves, where conventional catheters were unable to reach. We used this in three of our patients for assessment of pulmonary artery pressures and in two patients for assessment of pressures across a prosthetic St Jude® valve. Out of the three patients referred for assessment, only two had significantly raised distal pulmonary pressures enabling them to receive appropriate therapy. Out of the two patients with a prosthetic tricuspid valve, only one required surgery based on this assessment. We describe a novel use of the pressure wire in the functional assessment of adults with congenital cardiac disease in whom conventional catheter techniques may not be able to provide adequate data. It can be a guide to provide appropriate therapy and avoid unnecessary interventions in this patient group.

scholarly journals Multiple myeloma and physical activity

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Catherine S. Y. Lecat ◽  
Orla McCourt ◽  
Joanne Land ◽  
Kwee Yong ◽  
Abigail Fisher
Keyword(s):  
Quality Of Life ◽  
Physical Activity ◽  
Multiple Myeloma ◽  
Functional Assessment ◽  
Chronic Illness Therapy ◽  
Physical Activity Advice ◽  
Related Quality ◽  
Health Related ◽  
To Receive

Abstract Objective Physical activity has been shown to improve quality of life in cancer patients with some evidence in multiple myeloma. This study aimed to determine myeloma patients’ exercise levels, their perception of physical activity, and to explore correlations with quality of life. Myeloma outpatients were invited to complete a number of questionnaires, including the Godin leisure-time exercise questionnaire (GLTEQ) to determine their exercise levels, the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire to assess health related quality of life, and the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) questionnaire to assess fatigue. Results Of the 65 respondents, 75% would like to increase their exercise level. Weakness, fatigue and pain were the most commonly perceived barriers to physical activity. 59% would like to receive physical activity advice. Only 25% were deemed active based on their GLTEQ scores. Finally, there was a significant positive correlation between the GLTEQ score and the FACT-G score (p < 0.001). Results highlight an unmet exercise need in myeloma patients. Current practice should be reviewed to develop a more holistic care model that incorporates tailored exercise advice or programme.

scholarly journals Clinical Outcome after Plaster Cast Fixation for 10 Days Versus 1 Month in Reduced Distal Radius Fractures: A Prospective Randomized Study

2017 ◽  
Vol 107 (1) ◽  
pp. 82-90 ◽  
Author(s):  
A. Christersson ◽  
S. Larsson ◽  
B. Sandén
Keyword(s):  
Distal Radius ◽  
Functional Assessment ◽  
Randomized Study ◽  
Plaster Cast ◽  
Distal Radius Fractures ◽  
Active Group ◽  
Control Group ◽  
Radius Fractures ◽  
Assessment Scores

Introduction: This study aimed to evaluate clinical results after plaster cast fixation for 10 days versus 1 month of moderately displaced and reduced distal radius fractures. Material and Methods: In a prospective randomized study, 109 patients with moderately displaced and conservatively treated distal radius fractures (age ≥50 years) were randomized 10 days after reduction to either removal of the plaster cast and immediate mobilization (active group) or to continued plaster cast fixation for another 3 weeks (control group). Grip strength, pincer strength, range of motion, and pain were assessed at 1, 4, and 12 months after reduction. Clinical outcome was evaluated using three functional assessment scores at 12 months. Results: Treatment failed in 3/54 (6%) patients in the active group. One of these patients had the plaster cast reinstituted because of feelings of instability. The fractures in the other two patients displaced severely after mobilization and were therefore treated surgically. For the remaining 51 patients in the active group, the range of wrist motion was slightly better at 1 month compared with the controls, but there were no differences in grip or pincer strength or pain at the 1-month follow-up. There were no differences between the active and control group in any outcome at 4 or 12 months, including functional assessment scores at 12 months. Conclusion: Treatment with mobilization 10 days after reduction of moderately displaced distal radius fractures resulted in a few treatment failures compared with none among controls. The only functional benefit for the remaining patients was a small and transient increase in range of motion at the 1-month follow-up. Plaster cast removal 10 days after reduction in moderately displaced distal radius fractures is therefore not recommended.

scholarly journals P.064 Sex differences in patients referred to a rural and remote memory clinic

2017 ◽  
Vol 44 (S2) ◽  
pp. S29-S29
Author(s):  
OM Philippon ◽  
A Kirk ◽  
C Karunanayake ◽  
D Morgan
Keyword(s):  
Sex Differences ◽  
Daily Living ◽  
Demographic Data ◽  
Initial Presentation ◽  
Remote Memory ◽  
Memory Clinic ◽  
Rural And Remote ◽  
Assessment Scores ◽  
Mini Mental Status Examination ◽  
To Receive

Background: Dementia is more prevalent in women. Sex differences exist as the disease progresses (e.g. males are more likely to become aggressive). In many medical illnesses (e.g. cardiac disease), there are differences in presentation between men and women. The current study explores sex differences at the patients’ initial presentation to the Rural and Remote Memory Clinic (RRMC). Methods: Patients were referred to the RRMC in Saskatoon, Saskatchewan. Cognitive and demographic data were collected. Questionnaires included cognitive (e.g. Mini-Mental Status Examination) and daily living (e.g. Instrumental Activities of Daily Living) assessments. Results: Three hundred and seventy-five (159 male, 216 female) patients participated. Of these patients, 146 (49 male, 97 female) were diagnosed with Alzheimer’s disease. Males and females presented to the clinic at similar ages. Females were more likely to have a son or daughter caregiver and to live alone. Males were more likely to be currently working and to be a former smoker. No statistically significant differences were found for cognitive assessment scores. Conclusions: Analysis of the initial presentation of patients to the RRMC revealed females and males had similar presentation in measures of cognitive impairment. This may be reassuring for patients and their families knowing their family member, regardless of sex, is receiving equivalent referral to receive care.

scholarly journals Can AM-PAC “6-Clicks” Inpatient Functional Assessment Scores Strengthen Hospital 30-Day Readmission Prevention Strategies?

Cureus ◽  
2021 ◽  
Author(s):  
Scott M Arnold ◽  
James M Naessens ◽  
Kimberly McVeigh ◽  
Launia J White ◽  
James W Atchison ◽  
...  
Keyword(s):  
Functional Assessment ◽  
Prevention Strategies ◽  
Assessment Scores ◽  
Readmission Prevention

scholarly journals Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

2021 ◽  
pp. JCO.20.03488
Author(s):  
Kim N. Chi ◽  
Simon Chowdhury ◽  
Anders Bjartell ◽  
Byung Ha Chung ◽  
Andrea J. Pereira de Santana Gomes ◽  
...  
Keyword(s):  
Functional Assessment ◽  
Progression Free Survival ◽  
Phase Iii ◽  
Health Related Quality ◽  
Castration Resistance ◽  
Free Survival ◽  
Related Quality ◽  
Health Related ◽  
To Receive

PURPOSE The first interim analysis of the phase III, randomized, placebo-controlled TITAN study showed that apalutamide significantly improved overall survival (OS) and radiographic progression-free survival in patients with metastatic castration-sensitive prostate cancer (mCSPC) receiving ongoing androgen deprivation therapy (ADT). Herein, we report final efficacy and safety results after unblinding and placebo-to-apalutamide crossover. METHODS Patients with mCSPC (N = 1,052) were randomly assigned 1:1 to receive apalutamide (240 mg QD) or placebo plus ADT. After unblinding in January 2019, placebo-treated patients were allowed to receive apalutamide. Efficacy end points were updated using the Kaplan-Meier method and Cox proportional-hazards model without formal statistical retesting and adjustment for multiplicity. Change from baseline in Functional Assessment of Cancer Therapy-Prostate total score was assessed. RESULTS With a median follow-up of 44.0 months, 405 OS events had occurred and 208 placebo-treated patients (39.5%) had crossed over to apalutamide. The median treatment duration was 39.3 (apalutamide), 20.2 (placebo), and 15.4 months (crossover). Compared with placebo, apalutamide plus ADT significantly reduced the risk of death by 35% (median OS not reached v 52.2 months; hazard ratio, 0.65; 95% CI, 0.53 to 0.79; P < .0001) and by 48% after adjustment for crossover (hazard ratio, 0.52; 95% CI, 0.42 to 0.64; P < .0001). Apalutamide plus ADT delayed second progression-free survival and castration resistance ( P < .0001 for both). Health-related quality of life, per total Functional Assessment of Cancer Therapy-Prostate, in both groups was maintained through the study. Safety was consistent with previous reports. CONCLUSION The final analysis of TITAN confirmed that, despite crossover, apalutamide plus ADT improved OS, delayed castration resistance, maintained health-related quality of life, and had a consistent safety profile in a broad population of patients with mCSPC.

scholarly journals The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial

2019 ◽  
Author(s):  
Yanhong Su ◽  
Jiajia Huang ◽  
Shusen Wang ◽  
Joseph M Unger ◽  
Jonathan Arias-Fuenzalida ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Adverse Events ◽  
Cancer Treatment ◽  
Functional Assessment ◽  
Statistical Tests ◽  
Eastern Cooperative Oncology Group ◽  
Motor Neuropathy ◽  
Oncology Group ◽  
Peripheral Neurotoxicity ◽  
To Receive

Abstract Background Taxane-induced peripheral neuropathy (TIPN) is a dose-limiting adverse effect. Ganglioside-monosialic acid (GM1) functions as a neuroprotective factor. We assessed the effects of GM1 on the prevention of TIPN in breast cancer patients. Methods We conducted a randomized, double-blind, placebo-controlled trial including 206 patients with early-stage breast cancer planning to receive taxane-based adjuvant chemotherapy with a follow-up of more than 1 year. Subjects were randomly assigned to receive GM1 (80 mg, day −1 to day 2) or placebo. The primary endpoint was the Functional Assessment of Cancer Treatment Neurotoxicity subscale score after four cycles of chemotherapy. Secondary endpoints included neurotoxicity evaluated by National Cancer Institute Common Terminology Criteria for Adverse Events Version 4.0 and the Eastern Cooperative Oncology Group neuropathy scale. All statistical tests were two-sided. Results In 183 evaluable patients, the GM1 group reported better mean Functional Assessment of Cancer Treatment Neurotoxicity subscale scores than patients in the placebo group after four cycles of chemotherapy (43.27, 95% confidence interval [CI] = 43.05 to 43.49 vs 34.34, 95% CI = 33.78 to 34.89; mean difference = 8.96, 95% CI = 8.38 to 9.54, P < .001). Grade 1 or higher peripheral neurotoxicity in Common Terminology Criteria for Adverse Events v4.0 scale was statistically significantly lower in the GM1 group (14.3% vs 100.0%, P < .001). Additionally, the GM1 group had a statistically significantly lower incidence of grade 1 or higher neurotoxicity assessed by Eastern Cooperative Oncology Group neuropathy scale sensory neuropathy (26.4% vs 97.8%, P < .001) and motor neuropathy subscales (20.9% vs 81.5%, P < .001). Conclusions The treatment with GM1 resulted in a reduction in the severity and incidence of TIPN after four cycles of taxane-containing chemotherapy in patients with breast cancer.

scholarly journals Applying Mindfulness Therapy in a Group of Psychotic Individuals: A Controlled Study

2011 ◽  
Vol 40 (1) ◽  
pp. 105-109 ◽  
Author(s):  
Álvaro I. Langer ◽  
Adolfo J. Cangas ◽  
Estela Salcedo ◽  
Belén Fuentes
Keyword(s):  
Cognitive Therapy ◽  
Waiting List ◽  
Controlled Study ◽  
Control Group ◽  
Control Groups ◽  
And Control ◽  
To Receive ◽  
Experimental Group ◽  
Mindfulness Therapy

Background: There are already several existing studies that show the effectiveness of mindfulness-based approaches in varying types of disorders. Only a few studies, however, have analyzed the effectiveness of this intervention in psychosis, and without finding, up to now, significant differences from the control group. Aims: The aim of this study is two-fold: to replicate previous studies, and to focus on analyzing the feasibility and effectiveness of applying mindfulness in a group of people with psychosis. Method: Eighteen patients with psychosis were randomly assigned to experimental and control groups. The experimental group received eight 1-hour sessions of Mindfulness-Based Cognitive Therapy (MBCT), while the control group was relegated to a waiting list to receive MBCT therapy. Results: The experimental group scored significantly higher than the control group in their ability to respond mindfully to stressful internal events. Conclusions: Both the usefulness and effectiveness of implementing a mindfulness-based program have been replicated in a controlled manner in patients with psychosis.

scholarly journals Portable Ultrasound Device Usage and Learning Outcomes Among Internal Medicine Trainees: A Parallel-Group Randomized Trial

2019 ◽  
pp. 154-159 ◽  
Author(s):  
Andre Kumar ◽  
Yingjie Wang ◽  
Jason Bentley ◽  
Libo Wang ◽  
Jason Bentley ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Point Of Care ◽  
Image Interpretation ◽  
Portable Ultrasound ◽  
Assessment Scores ◽  
Lecture Series ◽  
Group Randomized Trial ◽  
The Difference ◽  
Point Of Care Ultrasonography ◽  
To Receive

BACKGROUND: Little is known about how to effectively train residents with point-of-care ultrasonography (POCUS) despite increasing usage. OBJECTIVE: This study aimed to assess whether handheld ultrasound devices (HUDs), alongside a year-long lecture series, improved trainee image interpretation skills with POCUS. METHODS: Internal medicine intern physicians (N = 149) at a single academic institution from 2016 to 2018 participated in the study. The 2017 interns (n = 47) were randomized 1:1 to receive personal HUDs (n = 24) for patient care vs no-HUDs (n = 23). All 2017 interns received a repeated lecture series regarding cardiac, thoracic, and abdominal POCUS. Interns were assessed on their ability to interpret POCUS images of normal/abnormal findings. The primary outcome was the difference in end-of-the-year assessment scores between interns randomized to receive HUDs vs not. Secondary outcomes included trainee scores after repeating lectures and confidence with POCUS. Intern scores were also compared with historical (2016, N = 50) and contemporaneous (2018, N = 52) controls who received no lectures. RESULTS: Interns randomized to HUDs did not have significantly higher image interpretation scores (median HUD score: 0.84 vs no-HUD score: 0.84; P = .86). However, HUD interns felt more confident in their abilities. The 2017 cohort had higher scores (median 0.84), compared with the 2016 historical control (median 0.71; P = .001) and 2018 contemporaneous control (median 0.48; P < .001). Assessment scores improved after first-time exposure to the lecture series, while repeated lectures did not improve scores. CONCLUSIONS: Despite feeling more confident, personalized HUDs did not improve interns’ POCUS-related knowledge or interpretive ability. Repeated lecture exposure without further opportunities for deliberate practice may not be beneficial for mastering POCUS.

Geographic distribution of point-in-time access to subsidised dental services in Western Australia

2016 ◽  
Vol 22 (6) ◽  
pp. 569 ◽  
Author(s):  
Yevgeni Dudko ◽  
Estie Kruger ◽  
Marc Tennant
Keyword(s):  
Dental Care ◽  
Human Services ◽  
Dental Health ◽  
Population Data ◽  
Waiting List ◽  
Dental Services ◽  
Eligible Population ◽  
Receive Treatment ◽  
Australian Bureau Of Statistics ◽  
To Receive

Dental Health Services (DHS) is the largest public primary oral healthcare provider in WA. The objective of this study was to calculate probable distance patients are expected to travel to the nearest clinic, gauge utilisation rates and predict the direction of likely changes in future demand for subsidised dental care. Eligible population data was collected from the Department of Human Services and the Australian Bureau of Statistics websites and integrated with the waiting list and the recall list data provided by the DHS. In total, 65% of the eligible WA population are residing in the metropolitan area; however, only 19% of those are either on the waiting list or have already received subsidised care. In all, 35% of the total eligible WA population are residing in country areas. A total of 30% of the eligible country WA patients are located within a 100-km range of a Government Dental Clinic, with only 11% of those either on the waiting list or having already received subsidised dental care. Country WA residents are at a significant disadvantage by comparison to their metropolitan counterparts. Eligible WA country residents are up to 40% less likely to receive treatment when compared to the metropolitan residents.

Sign in / Sign up

Export Citation Format

Share Document